chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient began experiencing mild itchiness in throat and mild flushing sensation 5 mins after vaccine administration. VSS. No respiratory distress. Symptoms resolved after Benadryl 50mg given IM in R deltoid. Monitored for 1 hour post vaccine. Followed up again 5 hours later, patient reported symptoms resolved and denied any other adverse reaction to vaccine.
Patient received Moderna Bivalent booster instead of Moderna (primary series) for second dose.  Called patient to notify of mix up and patient came back to get Moderna second dose.
patient experienced Shingles after the administration of 1st and 2nd dose / suspected vaccination failure; patient experienced Shingles after the administration of 1st and 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was not reported, but was selected adult as per vaccine indication. The reporter enquired if a patient who experienced Shingles after the administration of 1st and 2nd dose, needs to repeat the series, did we have clinical studies on this. The healthcare professional declined to provided any details (Name, phone) from him and patient. No further clarifications provided. This case was considered as suspected vaccination failure as details regarding laboratory test confirmation and time to onset for the event was unknown at the time of reporting. The permission to follow up was denied.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020199108:same patient (1st dose)
Starting on 12/28/2022 I had body aches, weakness, cough and nausea. On 12/29/2022 I had a covid test and it was positive.  12/31/2022 my provider prescribed Paxlovid for treatment. I took another COVID-19 test on 01/06/2023 and it was negative. I returned to work on 01/10/2023. I have a cough still.
Left side eye was swollen/ but part of her eyes red and kind of swollen.; Left side eye was red/ part of eye is red.; Left side eye was  watery; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Left side eye was swollen/ but part of her eyes red and kind of swollen.), OCULAR HYPERAEMIA (Left side eye was red/ part of eye is red.) and LACRIMATION INCREASED (Left side eye was  watery) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2022, the patient experienced EYE SWELLING (Left side eye was swollen/ but part of her eyes red and kind of swollen.), OCULAR HYPERAEMIA (Left side eye was red/ part of eye is red.) and LACRIMATION INCREASED (Left side eye was  watery). At the time of the report, EYE SWELLING (Left side eye was swollen/ but part of her eyes red and kind of swollen.) and OCULAR HYPERAEMIA (Left side eye was red/ part of eye is red.) had not resolved and LACRIMATION INCREASED (Left side eye was  watery) outcome was unknown. No concomitant medication was reported.   It was reported that the patient took second booster dose.  No treatment medications was reported.
Injection site swollen x 3 weeks; flu-like symptoms (fever, fatigue, nausea) x 2 weeks; possible visual acuity involvement (per personal optometrist, via possible immune response).
My tongue started tingling within one hour, I has a headache for a day and a half. I slept almost all day after the first 24 hours. My eyes started getting blurry, burning after 4 hours and are still bothering me. My tongue has been burning ten days after the vaccine on Saturday on June 26th. I need to see an opthalmologist now for my eyes. My appointment is on July 8th. The healthdepartment did not give me a information sheet about the vaccine or even put their sticker on my vaccine card. I have tried to call the health department  and they are blowing me off.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 27-APR-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L040178, expiration date 18-AUG-2017). This specified lot number vaccine was exposed to temperature excursion two times. The total cumulative excursion time of the first time was 136 hours with the lowest recorded temperature of 33 Fahrenheit degree. The total cumulative excursion time of the second time was 40 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
1. Hair follicle pain - started a few hours after injection, still having 2 days later 2. Itching all over body - started 32 hours after injection, still itchy the next day
Initial report received from a pharmacist on 23 October 2013. A 31 year old female patient whose medical history and concomitant medications were not reported, received dose one of FLUZONE INTRADERMAL (batch no: UT4722BA) (route, site of administration not reported) on an unspecified date. Patient saw redness from her wrists to her elbows 2-3 hours after vaccine administration. She was fine when the pharmacist followed up in the evening. Lab investigation and corrective treatment were not reported. At the time of this report, the event was recovered. Documents held by sender: none
Information has been received from a consumer concerning his brother's "10 years old" daughter who was vaccinated with MMR II "at age 2". "Within hours of getting the vaccine" the patient almost died from idiopathic thrombocytopenic purpura (ITP). The patient was hospitalized for several days. On unspecified date the patient recovered from idiopathic thrombocytopenic purpura. No further information is available.
Manufacture Expiration date (9/30/2022) where the vaccine was administered the day after (10/01/2022) said expiration date. The vaccine was taken out of the freezer on 09/13/2022 and kept in the refrigerator until the date of administration.
This spontaneous report concerning a patient of unknown gender and age with pneumonia was received from a registered nurse. Medical history include therapy with (PREVNAR) for unknown indication. On 30-JUN-2016, the patient was vaccinated with an expired dose of PNEUMOVAX23 lot # K019386, expiration date: 09-JUN-2016 (strength, dose, route and frequency were not reported. No concomitant medications and adverse events were reported. No product quality complain was involved. Additional information has been requested.
I got my COVID Vaccine like back in December and January  then I actually got COVID in August, I also lost smell and taste with it and I was barely getting my smell back; I got my COVID Vaccine like back in December and January  then I actually got COVID in August, I also lost smell and taste with it and I was barely getting my smell back; I got my COVID Vaccine like back in December and January  then I actually got COVID in August, I also lost smell and taste with it and I was barely getting my smell back; I got my COVID Vaccine like back in December and January  then I actually got COVID in August, I also lost smell and taste with it and I was barely getting my smell back; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 25-year-old female patient received bnt162b2 (BNT162B2), administration date Dec2020 (Batch/Lot number: unknown) as dose 1, single and administration date Jan2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Allergy" (unspecified if ongoing), notes: Verbatim: Allergy. Concomitant medication(s) included: MONTELUKAST taken for hypersensitivity. Vaccination history included: Flu shot (I got my flu shot like 2 months ago), administration date: 2021. The following information was reported: SUSPECTED COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 04Aug2021, outcome "unknown" and all described as "I got my COVID Vaccine like back in December and January then I actually got COVID in August, I also lost smell and taste with it and I was barely getting my smell back"; AGEUSIA (non-serious) with onset Aug2021, outcome "unknown", ANOSMIA (non-serious) with onset Aug2021, outcome "recovering" and all described as "I got my COVID Vaccine like back in December and January then I actually got COVID in August, I also lost smell and taste with it and I was barely getting my smell back". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (18Aug2021) negative, notes: I got COVID on the 4Aug and then literally after 14 days my result came negative. Therapeutic measures were not taken as a result of suspected covid-19, ageusia, anosmia. Patient was 24-years old at vaccination. She is Physician Assistant student. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient stated that she got covid Vaccine like back in December and January like it was Pfizer vaccine and then she actually got covid in August, this year August and then she had all the senses, then she also lost smell and taste with it and was barely getting her smell back and as soon as patient got the booster, she lost her smell again and noticed the concerned thing she was getting her smell back and as soon as she got the covid, she thought in 48 hours couldn't smell those things again.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient received 2nd dose of Pfizer vaccine 2 weeks (14 days) following 1st dose of Pfizer vaccine
Right when the patient sat down at observation she stated she was flushed and got hot in her head. She said her chest felt funny and her tongue was tingly. Her blood pressure was 169/95 and heart rate was 100. She stated she was nervous.  We kept her in observation for 30 minutes. All symptoms resolved by the time she left.
Ataxia, Dizziness, Diplopia.  Diagnosed with ADEM.  Currently recovering on steroids, pending neuroimmunology evaluation
Pt states he left the Health Dept & went home, at home he states he fainted then got up and went to school. He states he began having stomach spasms at school. He returned to the health Dept at 12:00. B/P 94/64. Abdomen rigid. Referred to ER. Pt's brother was with him & drove. Will follow up with pt. Left message for a return call.
1st day after tired,2nd day headache,dizzy,profuse sweating,vomitting,3rd day,slight rash on trunk
Nausea; Headache; This case was reported by a other health professional via call center representative and described the occurrence of nausea in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In February 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced nausea and headache. On an unknown date, the outcome of the nausea and headache were recovered/resolved.   It was unknown if the reporter considered the nausea and headache to be related to Shingrix.  Additional details were reported as follows: The nausea and headache completely resolved within 24 hours. The reporter consented to follow up. HCP could not provide lot number or expiration date of product.
Painful, itchy rash, cellulitis, redness, swelling of arm at injection site.  Antibiotic (Keflex) given Medrol dose pack Symptoms resolved
Lymph node in left armpit, "extremely large". Seen at base medical facility. No RX. Is resolving and getting better.
Flushed feeling in face within 3 hours of the injection, followed shortly by headache. 10 hours post injection, fever and chills were present. Profuse sweating most likely due to fever and extreme arm soreness for the first 24 hours. Headache remains through day 2 post injection. Fever and chills subsided around the 24 hour mark. Day 2 arm soreness, redness, and swelling at injection site. Pain in chest, shoulder blade, and shoulder of the injected side feels like muscle soreness similar to that experienced after a hard workout Day 2: discover presence of lump near neck just above collar bone I am inclined to believe it is an inflamed lymph node, but I am no doctor).
Information has been received from a physician concerning a female (age unknown), who on an unspecified date, was vaccinated with a first dose of Gardasil. Subsequently, the patient fainted after the vaccine was administered. The patient was either sitting or standing when the vaccine was administered. The patient sought unspecified medical attention. The patient recovered on an unspecified date. No product quality complaint was involved. This is 1 of three reports from the same source. Additional information has been requested.
Pt. c/o swelling around vaccine site. Started next day -> itchy. Today measures 40 mm x 50 mm. Still itchy some redness - mild swelling noted today on exam. Local redness & mild swelling.
Arthralgia, Fever,  SWELLING IN BETWEEN EYEBROWS. NO HISTORY OF FILLERS
Large inflammation at injection site and started getting pain and welts under rib cage. Pain and increased welts under rib cage have continued for 2 days so far. Dr. diagnosis is Shingles.
Injection site soreness, tiredness, headache, muscle soreness, chills, joint soreness.
Information has been received from a registered nurse (R.N.) concerning a male child in elementary school (who is between grades 3-5) who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). It was reported that a outbreak of chickenpox began in an elementary school in November 2005. "Recently", "since November" the male  child developed chickenpox and sought unspecified medical attention. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
Pt recvd 3 doses of Engerix-B 6JUN91, 26JUL91 & 3JAN92 & on 26MAR92 pt titer was non-reactive; 4th dose Engerix-B has been given; pt currently takes Buspar for anxiety;
Extreme fatigue , aches, headache and nausea. Right arm very sore for about three days. No respiratory problems.  Food doesn't taste normal.  Felt just as bad as when  I had Covid 19.  Very little strength to get out of bed and slept all day into the night.  Took shot on Monday, then sick all day the following Tuesday.  On Wednesday I was better , but was still very fatigued and had mild headaches . By Thursday was back to normal.
Soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in the arm) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in the arm). At the time of the report, PAIN IN EXTREMITY (Soreness in the arm) outcome was unknown.            It was reported that the patient took some unspecified medications. No treatment medications were reported.   This case was linked to MOD-2022-445071, MOD-2022-445052 (Patient Link).
sore arm; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 73-year-old female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration in the right arm on 04Feb2021 09:00 (age at the time 73-year-old) as single dose for covid-19 immunization at pharmacy. The patient's medical history and no concomitant medications was not reported. The patient did not receive any other vaccine within 4 weeks. The patient previously received first dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration in the right arm on 15Jan2021 16:00 (age at the time 73-year-old) as single dose for covid-19 immunization. On 04Feb2021, the patient had a sore arm which she noticed pretty soon after the second shot. It went away three days later. She had fully recovered from the sore arm. Patient did not required visit to physician or ER. No investigation assessment was reported. The outcome for the event was resolved on 07Feb2021.  Information about lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
allergic reaction, BDI-rash over chest, upper back & amrs; mild breathing discomfort;
Large, red, inflamed area on arm for 2 weeks, painful, itchy. Used Benadryl cream for itching.
low grade fever; chills; shake uncontrollably; Flu like symptoms; tiredness; headache; nausea; feeling unwell; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6206; Expiration Date: 30Aug2021) via an unspecified route of administration and administered in left arm on 09Mar2021 as 0.3 ml single dose for COVID-19 immunization. The patient's medical history include osteoarthritis (that they called it osteoarthritis in her hip, but it is actually osteopenia). Concomitant medication included meloxicam (MELOXICAM) 15mg once a day by mouth as needed (which is the only prescription she takes, she says that her Meloxicam came in a pharmacy bottle, that says discard after 19Jul2021 and has a RX number on it. She says this prescription was filled 20Jul2020, so you can see how often she uses it. She says she doesn't take the meloxicam every day, and it has been at least two weeks since she took that), the only pills she takes are vitamin C and D and occasionally she takes something for her arthritis (no further details provided about vitamin C and D). She had the Pfizer COVID-19 vaccine tuesday and is having some side effect. She says some have gone away; some she is still having. She had her first Pfizer Covid vaccine shot last tuesday and woke up with a low-grade fever, chills, tiredness, headache, nausea, shake uncontrollably and feeling unwell. She says she has had a low-grade fever and chills to the point where she shakes uncontrollably. She says she woke up this morning doing the same thing. which does calm it down. She says her fever was 101.2, which she knows is low grade, today on thursday, and she had the vaccine on tuesday so she would like to know if it is normal to be having symptoms this far out from getting the shot. She says that it is flu like symptoms, and she almost feels like she has the flu. She says the vaccine card says 0.3mL BUD 6 hours at RT. She says that the expiry can 30Aug2021 or 30Jun2021. She says that the card says HCP clinic site LT. She says that tuesday was her first dose of the Pfizer COVID-19 vaccine. She says her temperature was 101.2 this morning when she got up, and she had chills and was shaking and she can't control them, unable to confirm temperature as being measured in fahrenheit during the call. She says that she took some Advil Liquigels 200mg, they are better when she takes the three Advil. She says she took the Advil today at 08:30 AM. Reporter says she has read all of the info, and she doesnt have all of the side effects and she doesnt have the severe ones, but this is Thursday, and she got the dose on Tuesday, can this be going on this long. On 11Mar2021, the patient underwent lab tests and procedures which included body temperature: 101.2. The clinical outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.
PT REPORTED HEAD FULLNESS, STIFFSNESS OR NECK, SLIGHT DIZZINESS  AND NAUSEA, PT STATED SHE IS IMMUNOCOMPROMISED AS SHE AHAS AN AUTOIMMUNE DISEASE AND CURRENTLY UNDERGOING CHEMO TREATMENTS AND ON CELLECOT. PT DENIES SOB, DYSPNEA. PAIN @INECTION SITE, ITCHINESS OR SWELLING. PT INSTRUCTED TO LAY HEAD FLAT AND ENCOURGE TO DRINK WATER VITAL SIGNS 93% ON RA AND HR 94BPM. AFTER ABOUT 20 MIN PT SATED SH NO LONGER FELT DIZZINESS, NAUSEA, PT STILLREPORTED HEAD FULLNESS AND NECK STIFFSNESS AND PT FINISHED 30 MIN OF OBSERVATION TIME AND LEFT.
Immediately after vaccines had headache and soreness of the arm. on 5/6 numbness of the arm and loss of strength, dry mouth.
Patient states that her menstrual cycle has been affected.  She started her period on the morning she received the vaccine.  She reports active bleeding for 13 days and then had a 4 day break in bleeding and then started bleeding again.  This is unusual for her.
Vaccine expired 9/21/2021 at 11:59pm.  Vaccine administered 9/22/2021 at 8:20am
This case was reported by a nurse via call center representative and described the occurrence of erythema of extremities in a 60-year-old female patient who received SHINGRIX (batch number 957J3, expiry date 15th November 2020) for prophylaxis. On 29th November 2018, the patient received the 2nd dose of SHINGRIX. On 29th November 2018, unknown after receiving SHINGRIX, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown. Additional details were received as follows: The patient received SHINGRIX was inadvertently reconstituted with sterile saline and administered to a patient, which led to drug reconstitution and inappropriate dose of vaccine administered. The reporter consented to follow up. Follow up information received from Nurse on 23rd January 2019: The reporter details were updated. On 29th November 2018, instead of using provided SHINGRIX diluent, nurse used sterile water & also gave injection with subcutaneous route instead of intramuscular route, which led to inappropriate route of vaccine administration. On 2nd December 2018, after 3 days, the patient's arm was streaked red. On 3rd December 2018, the patient contacted and redness was much better but at the time of reporting present. The patient never had a doctor visit and redness resolved. On 10th January 2019, the patient came to receive shot repeated with no problems vaccine series complete previous injection on 27th Sep 2018. At the time of this report, the outcome of the erythema of extremities was resolved and the outcome of the inappropriate route of vaccination and were unknown. It was unknown if the reporter considered the erythema of extremities to be related to SHINGRIX. The VAERS details were updated.